Search Orphan Drug Designations and Approvals
-
Generic Name: | darvadstrocel |
---|---|
Date Designated: | 02/22/2022 |
Orphan Designation: | Treatment of anal fistulas in patients without Crohn's disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Millennium Pharmaceuticals, Inc. (Millennium) 40 Landsdowne Street Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-